Unitary European Patent [0.03%]
统一的欧洲专利诉讼制度初探
Russell Thom
Russell Thom
Madaswamy S Muthu,Bajarangprasad L Pandey,Ashish K Sahu et al.
Madaswamy S Muthu et al.
Gareth Williams
Gareth Williams
Tatjana Mijatovic,François Dufrasne,Robert Kiss
Tatjana Mijatovic
The sodium pump, Na(+)/K(+)-ATPase, could be an important target for the development of anticancer drugs as it serves as a versatile signal transducer, plays a key role in cell adhesion and has abnormal expression and activity that are impl...
Current trends in the development of histone deacetylase inhibitors: a review of recent patent applications [0.03%]
组蛋白去乙酰化酶抑制剂的发展趋势：近期专利申请概述
Florian Thaler
Florian Thaler
Histone deacetylases (HDACs) have become an important target for the treatment of cancer and other diseases. Currently, more than ten HDAC inhibitors have entered clinical studies and two of them have already reached the market. The hydroxa...
Benedikt Sammet,Christian Steinkühler,Norbert Sewald
Benedikt Sammet
Antibody-drug conjugates (ADCs) for tumor therapy contain a cytotoxic drug conjugated to a monoclonal antibody (mAb) across a linker. A homing device, the mAb enables the recognition of tumor cells by binding to tumor-specific antigens. The...
Review of companies and drug classes in the 2007-2011 antihypertensive patent literature [0.03%]
2007-2011年抗高血压专利文献中的公司和药物种类分析
Philip A Carpino,Declan Flynn
Philip A Carpino
Hypertension, defined as elevated systolic blood pressure and/or diastolic blood pressure generally greater than 140/90 mmHg, is a significant risk factor for cardiovascular outcomes such as arterial aneurysm, myocardial infarction and stro...
Rita Bosetti,Lode Vereeck
Rita Bosetti
The success of nanomedicine is dependent upon an effective protection of IP rights. Unfortunately, the US nanomedicine patent system is dysfunctional because long R&D procedures as well as the patent pendency are insufficiently taken into a...
Jonathan Atkinson,Rachel Jones
Jonathan Atkinson
The EPO has faced the public perception that the barrier to patenting is too low and that patent quality has deteriorated. With this in mind, the EPO has initiated a process of strategic renewal called 'raising the bar' with a view to impro...
Patent protection in Europe of pharmaceuticals found to have a further medical indication [0.03%]
在欧洲药品发现进一步的医疗用途后可获得专利保护
Julian Cockbain
Julian Cockbain